BOFAS Abstracts Archive

You can search for abstracts by using the search bar below.
Alternatively you can browse through podium and poster presentations by selecting the year and / or type below. You can further refine your search using tags or use the search bar.

 



Categories: Abstracts, 2019, Poster

Long-term outcome of ankle replacements in patients with inflammatory joint disease and osteoarthritis: Is there a difference?

H. Majeed, J. Davenport, M. Karski, R. Smith, T. Clough

1Manchester University NHS Foundation Trust, Trauma & Orthopaedics, Manchester, United Kingdom

2Wrightington, Wigan and Leigh NHS Foundation Trust, Trauma & Orthopaedics, Wigan, United Kingdom 

Winner of the BOFAS 2019 3rd Best Poster Prize

Aims: We aim to provide long-term implant survival rates of total ankle replacement in patients with inflammatory joint disease and osteoarthritis.

Methods: Between November 1993 and February 2000, a single surgeon implanted 200 Scandinavian Total Ankle Replacement (STAR) prostheses (184 patients). Data were collected prospectively. Pain and function were assessed using American Orthopaedic Foot and Ankle Society (AOFAS) hindfoot scoring system. Failure was considered as re-operation with revision of one or all the components or conversion to arthrodesis.

Results: The underlying diagnosis was inflammatory joint disease in 119 and primary or posttraumatic osteoarthritis (OA) in 81 ankles. Mean age at implantation was 60 years with a significant difference in the two groups (IJD=58.2 years, OA= 62.6 years, p= 0.01). Mean follow-up was 15.8 years. Mean AOFAS scores were comparable in the two groups (IJD=61, OA=60). Nineteen patients were lost to follow up. In total 32 ankles required revision (16%); 14 in IJD (11.7%) and 18 in OA group (22.2%), significantly lower in IJD group (p=0.03). Average time from surgery to implant failure was 9.5 years in patients with IJD and 7.1 years in patients with OA. One hundred patients (113 ankles) died during the observation period, of which 87 patients (100 ankles) died without requiring revision surgery. Among the surviving 84 patients (87 ankles, IJD=40, OA=47), seven ankles in patients with IJD and twelve ankles in patients with OA required revision surgery. At 15.8 years, the overall implant survival was 76.16%. The implant survival was 81.95% in patients with IJD and 68.10% in patients with OA (p=0.03).

Conclusion: We report significantly better long-term implant survival rates in patients with inflammatory joint disease compared to OA after total ankle replacement with similar functional results. The predominant mode of failure was coronal plane malalignment in IJD and aseptic loosening in OA.

Previous Article Long-term follow up of TAR in patients with juvenile idiopathic arthritis
Next Article Low risk of delayed talar shift with functional management of the isolated Weber B fracture - results of a new treatment protocol.
Print


Click thumbnail below to view poster / thumbnail:

Archive of Abstracts

2024   -   Prize Winners  |  All Abstracts
2023   -   Prize Winners  |  All Abstracts
2022   -   Prize Winners  |  All Abstracts
2021   -   Prize Winners  
2019   -   Podium  |  Poster
2018   -   Podium  |  Poster
2017   -   Podium  |  Poster
2016   -   Podium  |  Poster
2015   -   Podium  |  Poster
2014   -   Podium  |  Poster
2013   -   Podium  |  Poster
2011   -   All Abstracts
2009   -   All Abstracts
2008   -   All Abstracts
2007   -   All Abstracts
2006   -   All Abstracts
2005   -   All Abstracts
2004   -   All Abstracts
2002   -   All Abstracts
2001   -   All Abstracts
2000   -   All Abstracts
1999   -   All Abstracts
1998   -   All Abstracts
1997   -   All Abstracts
1996   -   All Abstracts
1995   -   All Abstracts
1994   -   All Abstracts
1993   -   All Abstracts
1991   -   All Abstracts
1990   -   All Abstracts
1989   -   All Abstracts
1987   -   All Abstracts
1985   -   All Abstracts
1983   -   All Abstracts